N/A
Completed N=48
Attention Disengagement Training for Social Phobia
Source: ClinicalTrials.gov NCT00684320 ↗Enrolled (actual)
48
Serious AEs
0.0%
Results posted
May 2014
Primary outcomePrimary: Liebowitz Social Anxiety Scale (LSAS) — 68.1; 74.5; 60.0; 46.1 units on a scale
Summary
Generalized Social Phobia is characterized by severe social anxiety that leads to functional impairment (Schneider et al., 1992). Despite its high prevalence, many individuals do not receive treatment or are unresponsive to current therapies. Thus there is a clear need to continue to develop highly effective and efficient treatments for social phobia. This three year project aims to test a computerized treatment for social phobia in a double-blind, placebo-controlled study designed to modify attention biases that may maintain anxiety.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Liebowitz Social Anxiety Scale (LSAS) |
68.1; 74.5; 60.0; 46.1 | — |
| SECONDARY Social Phobia and Anxiety Inventory |
126.7; 132.3; 109.0; 99.1 | — |
Eligibility Criteria
Inclusion Criteria
- Principle DSM-IV-TR (APA, 2000) Diagnosis of social phobia - Generalized Type (GSP)
Exclusion Criteria
- No change in medication type or dosage twelve weeks prior to initiating treatment
- No current psychotherapy
- No evidence of suicidal intent
- No evidence of substance abuse in the last 6 months
- No evidence of current or past schizophrenia, bipolar disorder, or organic mental disorder
Data sourced from ClinicalTrials.gov (NCT00684320). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.